DALLAS, Oct. 13, 2026 /PRNewswire/ — Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in two upcoming investor conferences:

• Goldman Sachs Healthcare Private Company Conference — Andy Doraiswamy (CEO) will present on Monday, October 19, 2026, at the Goldman Sachs Client Center in New York City.
• The MedTech Conference, hosted by AdvaMed^® — Damian Rippole (CFO) will present as part of the Bank of America Company Presentations on Tuesday, October 20, 2026, in Room 050 at the Thomas M. Menino Convention & Exhibition Center in Boston.

Doraiswamy and Rippole will highlight the company’s commercial momentum for its vascular portfolio—including Dayspring^® non-pneumatic compression treatment for chronic edema—and share progress on its vascular pipeline and ongoing clinical research.

About Koya Medical

Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.

Learn more at www.koyamedical.com and follow Koya on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/koya-medical-to-present-at-october-2026-investor-conferences-302902990.html

SOURCE Koya Medical